MODERN ASPECTS OF COMBINED THERAPY OF COPD

Abstract

The epidemiology of COPD heavy burden of resources, healthcare and the economy. COPD affects 210 million people
worldwide and causes 3 million deaths per year (5% of all deaths worldwide). It is projected to become the third leading
cause of death worldwide by 2030. The economic burden of COPD is high, and the costs increase as the disease
progresses. Costs associated with severe COPD up to 17 times higher than those associated with mild COPD.Inflammation
in COPD is a major pathogenetic mechanism. Modern concepts and define COPD as a chronic inflammatory disease
associated with exposure to environmental factors.
The tasks of the modern treatment of COPD are to prevent progression of the disease, reducing the severity of clinical
symptoms, the achievement of a better exercise tolerance and quality of life of patients, prevention of complications and
exacerbations, and reduced mortality.